Correlation Between Brompton European and NeuPath Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Brompton European and NeuPath Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brompton European and NeuPath Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brompton European Dividend and NeuPath Health, you can compare the effects of market volatilities on Brompton European and NeuPath Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brompton European with a short position of NeuPath Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brompton European and NeuPath Health.

Diversification Opportunities for Brompton European and NeuPath Health

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Brompton and NeuPath is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Brompton European Dividend and NeuPath Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuPath Health and Brompton European is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brompton European Dividend are associated (or correlated) with NeuPath Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuPath Health has no effect on the direction of Brompton European i.e., Brompton European and NeuPath Health go up and down completely randomly.

Pair Corralation between Brompton European and NeuPath Health

Assuming the 90 days trading horizon Brompton European Dividend is expected to under-perform the NeuPath Health. But the etf apears to be less risky and, when comparing its historical volatility, Brompton European Dividend is 2.24 times less risky than NeuPath Health. The etf trades about -0.02 of its potential returns per unit of risk. The NeuPath Health is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  16.00  in NeuPath Health on August 31, 2024 and sell it today you would earn a total of  1.00  from holding NeuPath Health or generate 6.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Brompton European Dividend  vs.  NeuPath Health

 Performance 
       Timeline  
Brompton European 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Brompton European Dividend has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Brompton European is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
NeuPath Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NeuPath Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Brompton European and NeuPath Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Brompton European and NeuPath Health

The main advantage of trading using opposite Brompton European and NeuPath Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brompton European position performs unexpectedly, NeuPath Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuPath Health will offset losses from the drop in NeuPath Health's long position.
The idea behind Brompton European Dividend and NeuPath Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency